Optipharm.CO.LTD (153710) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Optipharm.CO.LTD (153710) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩315.25 Million ≈ $213.64K USD) by net assets (₩25.71 Billion ≈ $17.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Optipharm.CO.LTD - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Optipharm.CO.LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Optipharm.CO.LTD for a breakdown of total debt and financial obligations.

Optipharm.CO.LTD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Optipharm.CO.LTD ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Balatacilar Balatacilik Sanayi ve Ticaret AS IS:BALAT	-0.045x
Econpile Holdings Bhd KLSE:5253	0.006x
Cassiar Gold Corp V:GLDC	-0.247x
Estrella Resources Ltd AU:ESR	-0.064x
Ipopema Securities SA WAR:IPE	2.921x
Futuretech II Acquisition Corp NASDAQ:FTII	-3.681x
Shree Rama Newsprint Limited NSE:RAMANEWS	0.266x
BRAIN Biotech AG XETRA:BNN	-2.326x

Annual Cash Flow Conversion Efficiency for Optipharm.CO.LTD (2015–2024)

The table below shows the annual cash flow conversion efficiency of Optipharm.CO.LTD from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 153710 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩27.34 Billion ≈ $18.52 Million	₩-595.50 Million ≈ $-403.56K	-0.022x	+68.20%
2023-12-31	₩25.14 Billion ≈ $17.04 Million	₩-1.72 Billion ≈ $-1.17 Million	-0.069x	+18.34%
2022-12-31	₩29.01 Billion ≈ $19.66 Million	₩-2.43 Billion ≈ $-1.65 Million	-0.084x	-31.87%
2021-12-31	₩30.96 Billion ≈ $20.98 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.064x	-32.95%
2020-12-31	₩33.78 Billion ≈ $22.89 Million	₩-1.62 Billion ≈ $-1.10 Million	-0.048x	-480.82%
2019-12-31	₩35.61 Billion ≈ $24.13 Million	₩447.47 Million ≈ $303.24K	0.013x	-62.99%
2018-12-31	₩35.44 Billion ≈ $24.02 Million	₩1.20 Billion ≈ $815.47K	0.034x	+66.43%
2017-12-31	₩12.79 Billion ≈ $8.67 Million	₩260.86 Million ≈ $176.78K	0.020x	-68.03%
2016-12-31	₩13.50 Billion ≈ $9.15 Million	₩861.36 Million ≈ $583.73K	0.064x	+136.47%
2015-12-31	₩4.30 Billion ≈ $2.91 Million	₩-751.51 Million ≈ $-509.29K	-0.175x	--

About Optipharm.CO.LTD

KQ:153710 Korea Diagnostics & Research

Market Cap

$51.60 Million

₩76.14 Billion KRW

Market Cap Rank

#21761 Global

#1417 in Korea

Share Price

₩5190.00

Change (1 day)

-0.95%

52-Week Range

₩4850.00 - ₩6200.00

All Time High

₩28900.00